Citations (146)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (34)
Michael A. Ueberall & Gerhard Mueller-Schwefe. (2022) COMET – effectiveness and tolerability of methocarbamol versus oral opioid-analgesics as add-on measure in patients with non-specific low back pain refractory to recommended 1st line treatments. A retrospective analysis of depersonalized propensity score matched open-label real-world 4-week data from the German Pain e-Registry. Current Medical Research and Opinion 38:2, pages 237-253.
Read now
Read now
Michael A. Ueberall, Ute Essner, Gerhard Müller-Schwefe, Johannes Horlemann & Martin Storr. (2022) Prevalence of drug-induced constipation and severity of associated biopsychosocial effects in patients with nonmalignant pain: a cross-sectional review of depersonalized data from the German Pain e-Registry. Current Medical Research and Opinion 38:1, pages 101-114.
Read now
Read now
Shankar Ganesh & Mritunjay Kumar. (2021) Physiotherapist management of a patient with spastic perineal syndrome and subsequent constipation: a case report. Physiotherapy Theory and Practice 37:1, pages 242-251.
Read now
Read now
Joanne Patel, Catherine J. Lucas, Maxwell Margalit & Jennifer H. Martin. (2018) Laxative Use in Inpatients on Oxycodone/Naloxone Prolonged Release and Oxycodone Prolonged Release for Cancer and Non-cancer Pain. Journal of Pain & Palliative Care Pharmacotherapy 32:2-3, pages 116-123.
Read now
Read now
Gineke Koopmans-Klein, Joeri Van Op den Bosch, Yvonne van Megen, Hans Prenen, Frank Huygen & Isabelle Mancini. (2017) Prolonged release oxycodone and naloxone treatment counteracts opioid-induced constipation in patients with severe pain compared to previous analgesic treatment. Current Medical Research and Opinion 33:12, pages 2217-2227.
Read now
Read now
Krzysztof Nosek, Wojciech Leppert, Hanna Nosek, Jerzy Wordliczek & Dariusz Onichimowski. (2017) A comparison of oral controlled-release morphine and oxycodone with transdermal formulations of buprenorphine and fentanyl in the treatment of severe pain in cancer patients. Drug Design, Development and Therapy 11, pages 2409-2419.
Read now
Read now
María Dueñas, Liliane Mendonça, Rute Sampaio, Cláudia Gouvinhas, Daniela Oliveira, José Manuel Castro-Lopes & Luís Filipe Azevedo. (2017) Reliability and validity of the Bowel Function Index for evaluating opioid-induced constipation: translation, cultural adaptation and validation of the Portuguese version (BFI-P). Current Medical Research and Opinion 33:3, pages 563-572.
Read now
Read now
Stefano De Santis, Cristina Borghesi, Serena Ricciardi, Daniele Giovannoni, Alberto Fulvi, Maria Rita Migliorino & Claudio Marcassa. (2016) Analgesic effectiveness and tolerability of oral oxycodone/naloxone and pregabalin in patients with lung cancer and neuropathic pain: an observational analysis. OncoTargets and Therapy 9, pages 4043-4052.
Read now
Read now
Emiliano Petrò, Elena Ruffini, Melania Cappuccio, Valeria Guerini, Gloria Belotti, Sara Fascendini, Cristina Licini & Claudio Marcassa. (2016) Low-dose oral prolonged-release oxycodone/naloxone for chronic pain in elderly patients with cognitive impairment: an efficacy–tolerability pilot study. Neuropsychiatric Disease and Treatment 12, pages 559-569.
Read now
Read now
Michael A Ueberall & Gerhard H H Mueller-Schwefe. (2016) Efficacy and tolerability balance of oxycodone/naloxone and tapentadol in chronic low back pain with a neuropathic component: a blinded end point analysis of randomly selected routine data from 12-week prospective open-label observations. Journal of Pain Research 9, pages 1001-1020.
Read now
Read now
Michael A Ueberall, Alice Eberhardt & Gerhard HH Mueller-Schwefe. (2016) Quality of life under oxycodone/naloxone, oxycodone, or morphine treatment for chronic low back pain in routine clinical practice. International Journal of General Medicine 9, pages 39-51.
Read now
Read now
Fabio Guerriero, Anna Roberto, Maria Teresa Greco, Carmelo Sgarlata, Marco Rollone & Oscar Corli. (2016) Long-term efficacy and safety of oxycodone–naloxone prolonged release in geriatric patients with moderate-to-severe chronic noncancer pain: a 52-week open-label extension phase study. Drug Design, Development and Therapy 10, pages 1515-1523.
Read now
Read now
Matias Nilsson, Christina Brock, Jakob Lykke Poulsen, Niels Bindslev, Mark Berner Hansen, Lona Louring Christrup & AM Drewes. (2016) Short-term oxycodone treatment does not affect electrogenic ion transport in isolated mucosa from the human rectosigmoid colon. Scandinavian Journal of Gastroenterology 51:5, pages 538-547.
Read now
Read now
Gineke Koopmans-Klein, Michel F.M. Wagemans, Hans C.H. Wartenberg, Yvonne J.B. Van Megen & Frank J.P.M. Huygen. (2016) The efficacy of standard laxative use for the prevention and treatment of opioid induced constipation during oxycodone use: a small Dutch observational pilot study. Expert Review of Gastroenterology & Hepatology 10:4, pages 547-553.
Read now
Read now
Ron Goeree & Jeff Goeree. (2016) Cost-effectiveness analysis of oxycodone with naloxone versus oxycodone alone for the management of moderate-to-severe pain in patients with opioid-induced constipation in Canada. Journal of Medical Economics 19:3, pages 277-291.
Read now
Read now
Marzia Lazzari, Claudio Marcassa, Silvia Natoli, Roberta Carpenedo, Clarissa Caldarulo, Maria B Silvi & Mario Dauri. (2016) Switching to low-dose oral prolonged-release oxycodone/naloxone from WHO-Step I drugs in elderly patients with chronic pain at high risk of early opioid discontinuation. Clinical Interventions in Aging 11, pages 641-649.
Read now
Read now
Michael A Ueberall & Gerhard HH Mueller-Schwefe. (2015) Development of opioid-induced constipation: post hoc analysis of data from a 12-week prospective, open-label, blinded-endpoint streamlined study in low-back pain patients treated with prolonged-release WHO step III opioids. Journal of Pain Research 8, pages 459-475.
Read now
Read now
Marzia Lazzari, Maria Teresa Greco, Claudio Marcassa, Simona Finocchi, Clarissa Caldarulo & Oscar Corli. (2015) Efficacy and tolerability of oral oxycodone and oxycodone/naloxone combination in opioid-naïve cancer patients: a propensity analysis. Drug Design, Development and Therapy 9, pages 5863-5872.
Read now
Read now
Guido Fanelli & Andrea Fanelli. (2015) Developments in managing severe chronic pain: role of oxycodone–naloxone extended release. Drug Design, Development and Therapy 9, pages 3811-3816.
Read now
Read now
Wojciech Leppert. (2015) Emerging therapies for patients with symptoms of opioid-induced bowel dysfunction. Drug Design, Development and Therapy 9, pages 2215-2231.
Read now
Read now
Michael A. Ueberall & Gerhard H. H. Mueller-Schwefe. (2015) Safety and efficacy of oxycodone/naloxone vs. oxycodone vs. morphine for the treatment of chronic low back pain: results of a 12 week prospective, randomized, open-label blinded endpoint streamlined study with prolonged-release preparations. Current Medical Research and Opinion 31:7, pages 1413-1429.
Read now
Read now
Fabio Guerriero, Carmelo Sgarlata, Claudio Marcassa, Giovanni Ricevuti & Marco Rollone. (2015) Efficacy and tolerability of low-dose oral prolonged-release oxycodone/naloxone for chronic nononcological pain in older patients. Clinical Interventions in Aging 10, pages 1-11.
Read now
Read now
Sabine Hesselbarth, Kai Hermanns & Petra Oepen. (2015) Prolonged-release oxycodone/naloxone in opioid-naïve patients – subgroup analysis of a prospective observational study. Expert Opinion on Pharmacotherapy 16:4, pages 457-464.
Read now
Read now
Thomas Nolte, Ulf Schutter & Oliver Loewenstein. (2014) Cancer pain therapy with a fixed combination of prolonged-release oxycodone/naloxone: results from a non-interventional study. Pragmatic and Observational Research 5, pages 1-13.
Read now
Read now
Gineke Koopmans, Karen Simpson, Javier De Andrés, Eberhard Albert Lux, Michel Wagemans & Yvonne Van Megen. (2014) Fixed ratio (2:1) prolonged-release oxycodone/naloxone combination improves bowel function in patients with moderate-to-severe pain and opioid-induced constipation refractory to at least two classes of laxatives. Current Medical Research and Opinion 30:11, pages 2389-2396.
Read now
Read now
M. Lazzari, A. F. Sabato, C. Caldarulo, M. Casali, P. Gafforio, C. Marcassa & F. Leonardis. (2014) Effectiveness and tolerability of low-dose oral oxycodone/naloxone added to anticonvulsant therapy for noncancer neuropathic pain: an observational analysis. Current Medical Research and Opinion 30:4, pages 555-564.
Read now
Read now
L. Abramowitz, N. Béziaud, C. Caussé, B. Chuberre, F. A. Allaert & S. Perrot. (2013) Further validation of the psychometric properties of the Bowel Function Index for evaluating opioid-induced constipation (OIC). Journal of Medical Economics 16:12, pages 1434-1441.
Read now
Read now
L. Abramowitz, N. Béziaud, L. Labreze, V. Giardina, C. Caussé, B. Chuberre, F. A. Allaert & S. Perrot. (2013) Prevalence and impact of constipation and bowel dysfunction induced by strong opioids: a cross-sectional survey of 520 patients with cancer pain: DYONISOS study. Journal of Medical Economics 16:12, pages 1423-1433.
Read now
Read now
Philippe Ducrotté & Christian Caussé. (2012) The Bowel Function Index: a new validated scale for assessing opioid-induced constipation. Current Medical Research and Opinion 28:3, pages 457-466.
Read now
Read now
Kai Hermanns, Uwe Junker & Thomas Nolte. (2012) Prolonged-release oxycodone/naloxone in the treatment of neuropathic pain – results from a large observational study. Expert Opinion on Pharmacotherapy 13:3, pages 299-311.
Read now
Read now
William Dunlop, Reiner Uhl, Iftekhar Khan, Anna Taylor & Garry Barton. (2012) Quality of life benefits and cost impact of prolonged release oxycodone/naloxone versus prolonged release oxycodone in patients with moderate-to-severe non-malignant pain and opioid-induced constipation: a UK cost-utility analysis. Journal of Medical Economics 15:3, pages 564-575.
Read now
Read now
Benoît Coffin & Christian Caussé. (2011) Constipation assessment scales in adults: a literature review including the new Bowel Function Index. Expert Review of Gastroenterology & Hepatology 5:5, pages 601-613.
Read now
Read now
A.M. Rentz, P. van Hanswijck de Jonge, P. Leyendecker & M. Hopp. (2011) Observational, nonintervention, multicenter study for validation of the bowel function index for constipation in european countries. Current Medical Research and Opinion 27:1, pages 35-44.
Read now
Read now
Katri Elina Clemens & Gerd Mikus. (2010) Combined oral prolonged-release oxycodone and naloxone in opioid-induced bowel dysfunction: review of efficacy and safety data in the treatment of patients experiencing chronic pain. Expert Opinion on Pharmacotherapy 11:2, pages 297-310.
Read now
Read now
Articles from other publishers (112)
Andrew Neil Davies, Charlotte Leach, Claire Butler, Shuchita Dhwiren Patel, Kate Shorthose & Kabir Batsari. (2023) Opioid-induced constipation: a stepwise treatment algorithm feasibility study. BMJ Supportive & Palliative Care 13:e2, pages e446-e453.
Crossref
Crossref
Huijuan Cao, Yuyi Wang, Jingxu Su, Hong Zhao, Mei Han & Jian Ping Liu. (2023) Acupuncture for chronic constipation. Cochrane Database of Systematic Reviews 2023:4.
Crossref
Crossref
Yukiyoshi FujitaHisao Imai, Eriko HirutaTakashi MasunoShigeki YamazakiHajime TanakaTeruhiko KamiyaMitsuru SandohSatoshi TakeiKazuya AraiHiromi NishibaJunnosuke MogiShiro KoizukaTaeko SaitoKyoko ObayashiKyoichi KairaKoichi Minato. (2023) Efficacy and Safety of Naldemedine Administration for Opioid-Induced Constipation in Cancer Patients with Poor Performance Status. Journal of Palliative Medicine 26:4, pages 548-553.
Crossref
Crossref
K.R.J. Kistemaker, A. de Graeff, M. Crul, G. de Klerk, P.M. van de Ven, M.P. van der Meulen, L. van Zuylen & M.A.H. Steegers. (2023) Magnesium hydroxide versus macrogol/electrolytes in the prevention of opioid-induced constipation in incurable cancer patients: study protocol for an open-label, randomized controlled trial (the OMAMA study). BMC Palliative Care 22:1.
Crossref
Crossref
Teruhiko Kamiya, Hisao Imai, Yukiyoshi Fujita, Eriko Hiruta, Takashi Masuno, Shigeki Yamazaki, Hajime Tanaka, Mitsuru Sandoh, Satoshi Takei, Kazuya Arai, Hiromi Nishiba, Junnosuke Mogi, Shiro Koizuka, Taeko Saito, Kyoko Obayashi, Kyoichi Kaira & Koichi Minato. (2023) A Retrospective Study of the Efficacy and Safety of Naldemedine for Treatment of Opioid-Induced Constipation in Patients with Hepatobiliary Pancreatic Cancer. Medicina 59:3, pages 492.
Crossref
Crossref
Kristina Allen-Brady & Ashok K. Tuteja. 2023. Handbook of Gastrointestinal Motility and Disorders of Gut-Brain Interactions. Handbook of Gastrointestinal Motility and Disorders of Gut-Brain Interactions
375
389
.
Charles L. Rhee, Stacie K. Levine & Joseph W. Shega. 2023. Evidence-Based Practice of Palliative Medicine. Evidence-Based Practice of Palliative Medicine
147
154
.
Takahiro Higashibata, Jun Hamano, Takaomi Kessoku, Shinya Kajiura, Mami Hirakawa, Yoshiki Horie, Masaki Shimizu, Shunsuke Oyamada, Keisuke Ariyoshi, Kota Kihara, Yohei Yamanaka, Kumi Konishi, Kosuke Doki, Yasuyuki Takashima, Manabu Horiuchi, Masato Homma, Takeshi Yamada, Yoshiyuki Yamamoto, Toshikazu Moriwaki, Tatsuya Morita, Atsushi Nakajima & Hiroka Nagaoka. (2022) Rationale and design of a multicenter, double-blinded, randomized, placebo-controlled trial to investigate the effects of naldemedine on opioid-induced constipation for patients with cancer pain: A study protocol. Contemporary Clinical Trials Communications 29, pages 100967.
Crossref
Crossref
Michael A. Überall, Heinrich Binsfeld, Michael Küster, Silvia Maurer, Norbert Schürmann & Johannes Horlemann. (2022) Medikamenteninduzierte Verstopfung bei Patienten mit nicht tumorbedingten Schmerzen. Schmerzmedizin 38:5, pages 23-41.
Crossref
Crossref
Hisao Imai, Yukiyoshi Fujita, Eriko Hiruta, Takashi Masuno, Shigeki Yamazaki, Hajime Tanaka, Teruhiko Kamiya, Mitsuru Sandoh, Satoshi Takei, Kazuya Arai, Hiromi Nishiba, Junnosuke Mogi, Kyoichi Kaira & Koichi Minato. (2022) A retrospective study of the efficacy and safety of naldemedine for opioid‐induced constipation in thoracic cancer patients. Thoracic Cancer 13:16, pages 2301-2308.
Crossref
Crossref
V Vien Lee, Ni Yin Lau, David J Y Xi, Anh T L Truong, Agata Blasiak, Kewin T H Siah & Dean Ho. (2022) A Systematic Review of the Development and Psychometric Properties of Constipation-Related Patient-Reported Outcome Measures: Opportunities for Digital Health. Journal of Neurogastroenterology and Motility 28:3, pages 376-389.
Crossref
Crossref
Mia Schmidt-Hansen, Michael I Bennett, Stephanie Arnold, Nathan Bromham, Jennifer S Hilgart, Andrew J Page & Yuan Chi. (2022) Oxycodone for cancer-related pain. Cochrane Database of Systematic Reviews 2022:6.
Crossref
Crossref
Hiromi Nishiba, Hisao Imai, Yukiyoshi Fujita, Eriko Hiruta, Takashi Masuno, Shigeki Yamazaki, Hajime Tanaka, Teruhiko Kamiya, Masako Ito, Satoshi Takei, Masato Matsuura, Junnosuke Mogi, Koichi Minato & Kyoko Obayashi. (2022) Efficacy and Safety of Naldemedine for Patients with Cancer with Opioid-Induced Constipation in Clinical Practice: A Real-World Retrospective Study. Journal of Clinical Medicine 11:9, pages 2672.
Crossref
Crossref
Hanne Konradsen, Veronica Lundberg, Jan Florin & Anne-Marie Boström. (2022) Prevalence of constipation and use of laxatives, and association with risk factors among older patients during hospitalization: a cross sectional study. BMC Gastroenterology 22:1.
Crossref
Crossref
Michael A Überall, Christian Elling, Christoph Eibl, Gerhard HH Müller-Schwefe, Claudia Lefeber, Myriam Heine & Birgit Heckes. (2022) Tapentadol prolonged release in patients with chronic low back pain: real-world data from the German Pain eRegistry. Pain Management 12:2, pages 211-227.
Crossref
Crossref
Joelle BouSaba, Wassel Sannaa & Michael Camilleri. (2022) Update on the role of naldemedine in opioid-induced constipation in patients with chronic noncancer pain. Therapeutic Advances in Gastroenterology 15, pages 175628482210786.
Crossref
Crossref
Michael Camilleri. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
76
99
.
Kimberly A. Ramos, Ian E. James, Franck Skobieranda, David G. Soergel, Dennis Ruff & Michael J. Fossler. (2021) Two‐Part Phase 1 Multiple‐Ascending‐Dose Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of TRV734 in Healthy Adults. Clinical Pharmacology in Drug Development 11:1, pages 51-62.
Crossref
Crossref
Antoine Lemaire, Yoann Pointreau, Bérengère Narciso, François-Xavier Piloquet, Viorica Braniste & Jean-Marc Sabaté. (2021) Effectiveness of naloxegol in patients with cancer pain suffering from opioid-induced constipation. Supportive Care in Cancer 29:12, pages 7577-7586.
Crossref
Crossref
Akihiro Tokoro, Hisao Imai, Soichi Fumita, Toshiyuki Harada, Toshio Noriyuki, Makio Gamoh, Masaharu Okamoto, Yusaku Akashi & Yoshiyuki Kizawa. (2021) Opioid-Induced Constipation in Patients with Cancer Pain in Japan (OIC-J Study): A Post Hoc Analysis. Journal of Clinical Medicine 10:18, pages 4193.
Crossref
Crossref
Roberto De Giorgio, Furio Massimino Zucco, Giuseppe Chiarioni, Sebastiano Mercadante, Enrico Stefano Corazziari, Augusto Caraceni, Patrizio Odetti, Raffaele Giusti, Franco Marinangeli & Carmine Pinto. (2021) Management of Opioid-Induced Constipation and Bowel Dysfunction: Expert Opinion of an Italian Multidisciplinary Panel. Advances in Therapy 38:7, pages 3589-3621.
Crossref
Crossref
M Kuronen, S Hantunen, L Alanne, H Kokki, C Saukko, S Sjövall, K Vesterinen & M Kokki. (2020) Pregnancy, puerperium and perinatal constipation – an observational hybrid survey on pregnant and postpartum women and their age‐matched non‐pregnant controls. BJOG: An International Journal of Obstetrics & Gynaecology 128:6, pages 1057-1064.
Crossref
Crossref
Ulderico Freo, Maurizio Furnari, Francesco Ambrosio & Paolo Navalesi. (2020) Efficacy and tolerability of tapentadol for the treatment of chronic low back pain in elderly patients. Aging Clinical and Experimental Research 33:4, pages 973-982.
Crossref
Crossref
Andrew Davies, Charlotte Leach, Claire Butler, Amanda Gregory, Sarah Henshaw, Ollie Minton, Kate Shorthose & Kabir M. Batsari. (2021) Opioid-induced constipation in patients with cancer: a “real-world,” multicentre, observational study of diagnostic criteria and clinical features. Pain 162:1, pages 309-318.
Crossref
Crossref
Toshiki Mimura. 2021. Pelvic Floor Disorders. Pelvic Floor Disorders
741
752
.
Louisa Picco, Melissa Middleton, Raimondo Bruno, Michala Kowalski & Suzanne Nielsen. (2020) Validity and Reliability of the Computer-Administered Routine Opioid Outcome Monitoring (ROOM) Tool. Pain Medicine 21:12, pages 3645-3654.
Crossref
Crossref
Miku Iida, Kohime Oshita, Ryousuke Wakamatsu, Yusuke Nakano, Sumire Iwamoto, Hiroo Suto, Chinami Suzuki, Hideharu Obara, Akio Shibanami & Kazuya Hiura. (2020) Efficacy of Naldemedine and Sennoside for Opioid-induced Constipation: Retrospective Comparison Study Using the Inverse Probability of Treatment Weightingオピオイド誘発性便秘症に対するナルデメジンとセンノシドの有効性；IPTW法を用いた後方視的比較検討. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) 46:11, pages 672-678.
Crossref
Crossref
Charles E. Argoff. (2020) Opioid-induced Constipation. The Clinical Journal of Pain 36:9, pages 716-722.
Crossref
Crossref
Guillaume Gourcerol & Antoine Lemaire. (2020) Prise en charge de la constipation induite par les opioïdes : regards croisés d’un gastroentérologue et d’un médecin de la douleur. Douleurs : Évaluation - Diagnostic - Traitement 21:4, pages 147-154.
Crossref
Crossref
Erlania do Carmo Freitas, Geslaney Reis da Silva, Rudval Souza da Silva, Rita Narriman Silva de Oliveira Boery & Maria Patricia Milagres. (2020) Opioid-induced constipation in palliative care: state of the art. Revista de Pesquisa Cuidado é Fundamental Online, pages 1116-1124.
Crossref
Crossref
Shania Liu, Danijela Gnjidic, Asad E. Patanwala, George Rubin, Manuel Nielsen & Jonathan Penm. (2020) Effect of an electronic medical record design modification on laxative co-prescribing among hospitalised patients taking opioids: A before-and-after study. International Journal of Medical Informatics 140, pages 104172.
Crossref
Crossref
Priya Vijayvargiya, Michael Camilleri, Pooja Vijayvargiya, Patricia Erwin & M. Hassan Murad. (2020) Systematic review with meta-analysis: efficacy and safety of treatments for opioid-induced constipation. Alimentary Pharmacology & Therapeutics 52:1, pages 37-53.
Crossref
Crossref
Xiaomei Leng, Fengxiao Zhang, Shanglong Yao, Xisheng Weng, Kaizhi Lu, Gouzhong Chen, Ming Huang, Yuguang Huang, Xiaofeng Zeng, Michael Hopp & Guodong Lu. (2020) Prolonged-Release (PR) Oxycodone/Naloxone Improves Bowel Function Compared with Oxycodone PR and Provides Effective Analgesia in Chinese Patients with Non-malignant Pain: A Randomized, Double-Blind Trial. Advances in Therapy 37:3, pages 1188-1202.
Crossref
Crossref
O.D. Ostroumova, E.Yu. Shakhova & A.I. Kochetkov. (2020) Drug-induced constipation. Dokazatel'naya gastroenterologiya 9:1, pages 20.
Crossref
Crossref
Kristina Allen-Brady & Ashok K. Tuteja. 2020. Clinical and Basic Neurogastroenterology and Motility. Clinical and Basic Neurogastroenterology and Motility
463
475
.
Andrew Davies, Charlotte Leach, Ricardo Caponero, Andrew Dickman, David Fuchs, Judith Paice & Anton Emmanuel. (2019) MASCC recommendations on the management of constipation in patients with advanced cancer. Supportive Care in Cancer 28:1, pages 23-33.
Crossref
Crossref
Elisabeth C. W. Neefjes, Hanneke van der Wijngaart, Maurice J. D. L. van der Vorst, Diederik ten Oever, Hans J. van der Vliet, Aart Beeker, Christiaan A. Rhodius, Hendrik P. van den Berg, Johannes Berkhof & Henk M. W. Verheul. (2019) Optimal treatment of opioid induced constipation in daily clinical practice – an observational study. BMC Palliative Care 18:1.
Crossref
Crossref
Hu Cai, Qinfei Zhou, Guanai Bao, Xiangming Kong & Li-Yan Gong. (2019) Transcutaneous electrical nerve stimulation of acupuncture points enhances therapeutic effects of oral lactulose solution on opioid-induced constipation. Journal of International Medical Research 47:12, pages 6337-6348.
Crossref
Crossref
Wojciech Leppert & Krzysztof Nosek. (2019) Comparison of the Quality of Life of Cancer Patients with Pain Treated with Oral Controlled-Release Morphine and Oxycodone and Transdermal Buprenorphine and Fentanyl. Current Pharmaceutical Design 25:30, pages 3216-3224.
Crossref
Crossref
Deborah Wittig-Wells, Pam Sapp, Melinda Higgins, Erica Davis, Jessica Carter & Ani Jacob. (2019) Randomized Controlled Trial of a Natural Food-Based Fiber Solution to Prevent Constipation in Postoperative Spine Fusion Patients. Orthopaedic Nursing 38:6, pages 367-372.
Crossref
Crossref
Darren M. Brenner, Yiqun Hu, Catherine Datto, Dana Creanga & Michael Camilleri. (2019) A Randomized, Multicenter, Prospective, Crossover, Open-Label Study of Factors Associated With Patient Preferences for Naloxegol or PEG 3350 for Opioid-Induced Constipation. American Journal of Gastroenterology 114:6, pages 954-963.
Crossref
Crossref
Adam D Farmer, Asbjørn M Drewes, Giuseppe Chiarioni, Roberto De Giorgio, Tony O'Brien, Bart Morlion & Jan Tack. (2019) Pathophysiology and management of opioid‐induced constipation: European expert consensus statement. United European Gastroenterology Journal 7:1, pages 7-20.
Crossref
Crossref
Brian Hanson, Shazia Mehmood Siddique, Yolanda Scarlett & Shahnaz Sultan. (2019) American Gastroenterological Association Institute Technical Review on the Medical Management of Opioid-Induced Constipation. Gastroenterology 156:1, pages 229-253.e5.
Crossref
Crossref
Katherine Clark. 2019. Textbook of Palliative Care. Textbook of Palliative Care
219
237
.
John M. Streicher & Edward J. Bilsky. (2017) Peripherally Acting μ-Opioid Receptor Antagonists for the Treatment of Opioid-Related Side Effects: Mechanism of Action and Clinical Implications. Journal of Pharmacy Practice 31:6, pages 658-669.
Crossref
Crossref
Debbie Grønlund, Lene Vase, Stine Abildgaard Knudsen, Maria Christensen, Asbjørn Mohr Drewes & Anne Estrup Olesen. (2018) Comparison of subjective and objective measures of constipation – Employing a new method for categorizing gastrointestinal symptoms. Journal of Pharmacological and Toxicological Methods 94, pages 23-28.
Crossref
Crossref
Bart J. Morlion, Stefan A. Mueller‐Lissner, Renato Vellucci, Wojciech Leppert, Benoît C. Coffin, Sara L. Dickerson & Tony O'Brien. (2017) Oral Prolonged‐Release Oxycodone/Naloxone for Managing Pain and Opioid‐Induced Constipation: A Review of the Evidence. Pain Practice 18:5, pages 647-665.
Crossref
Crossref
Constanza Maximiano, Iker López, Cristina Martín, Luis Zugazabeitia, Juan L. Martí-Ciriquián, Miguel A. Núñez, Jorge Contreras, Michael Herdman, Susana Traseira & Mariano Provencio. (2018) An exploratory, large-scale study of pain and quality of life outcomes in cancer patients with moderate or severe pain, and variables predicting improvement. PLOS ONE 13:4, pages e0193233.
Crossref
Crossref
Adam D Farmer, Caroline Bruckner Holt, Thomas J Downes, Eugenio Ruggeri, Sara Del Vecchio & Roberto De Giorgio. (2018) Pathophysiology, diagnosis, and management of opioid-induced constipation. The Lancet Gastroenterology & Hepatology 3:3, pages 203-212.
Crossref
Crossref
Jakob L Poulsen, Esben B Mark, Christina Brock, Jens B Frøkjær, Klaus Krogh & Asbjørn M Drewes. (2018) Colorectal Transit and Volume During Treatment With Prolonged-release Oxycodone/Naloxone Versus Oxycodone Plus Macrogol 3350. Journal of Neurogastroenterology and Motility 24:1, pages 119-127.
Crossref
Crossref
Katherine Clark. 2018. Textbook of Palliative Care. Textbook of Palliative Care
1
19
.
Kyung-Hee Lee, Tae Won Kim, Jung-Hun Kang, Jin-Soo Kim, Jin-Seok Ahn, Sun-Young Kim, Hwan-Jung Yun, Young-Jun Eum, Sung Ae Koh, Min Kyoung Kim, Yong Sang Hong, Jeong Eun Kim & Gyeong-Won Lee. (2017) Efficacy and safety of controlled-release oxycodone/naloxone versus controlled-release oxycodone in Korean patients with cancer-related pain: a randomized controlled trial. Chinese Journal of Cancer 36:1.
Crossref
Crossref
Joanne Patel, Jennifer H. Martin & Catherine J. Lucas. (2017)
Comment on a paper by Dupoiron et al. “A phase
III
randomized controlled study on the efficacy and improved bowel function of prolonged‐release (
PR
) oxycodone‐ naloxone (up to 160/80 mg daily) versus oxycodone
PR
”
. European Journal of Pain 21:10, pages 1772-1773.
Crossref
Crossref
Francesco Amato, Silvia Ceniti, Sergio Mameli, Giovanni M. Pisanu, Renato Vellucci, Vincenzo Palmieri, Leonardo Consoletti, Dorotea Magaldi, Paolo Notaro & Claudio Marcassa. (2017) High dosage of a fixed combination oxycodone/naloxone prolonged release: efficacy and tolerability in patients with chronic cancer pain. Supportive Care in Cancer 25:10, pages 3051-3058.
Crossref
Crossref
C. Wolfert, M. Merbach, G. Stammler, O. Emrich, A. M. Meid, J. Burhenne, A. Blank & G. Mikus. (2017) Management von chronischem Schmerz mit retardiertem TilidinManagement of chronic pain using extended release tilidine. Der Schmerz 31:5, pages 516-523.
Crossref
Crossref
D. Dupoiron, A. Stachowiak, O. Loewenstein, A. Ellery, W. Kremers, B. Bosse & M. Hopp. (2017) A phase III randomized controlled study on the efficacy and improved bowel function of prolonged-release (PR) oxycodone-naloxone (up to 160/80 mg daily) vs oxycodone PR. European Journal of Pain 21:9, pages 1528-1537.
Crossref
Crossref
D. Dupoiron, A. Stachowiak, O. Loewenstein, A. Ellery, W. Kremers, B. Bosse & M. Hopp. (2017) Long-term efficacy and safety of oxycodone-naloxone prolonged-release formulation (up to 180/90 mg daily) - results of the open-label extension phase of a phase III multicenter, multiple-dose, randomized, controlled study. European Journal of Pain 21:9, pages 1485-1494.
Crossref
Crossref
Mia Schmidt-Hansen, Michael I Bennett, Stephanie Arnold, Nathan Bromham & Jennifer S Hilgart. (2017) Oxycodone for cancer-related pain. Cochrane Database of Systematic Reviews 2019:3.
Crossref
Crossref
D. Khemani, M. Camilleri, A. Roldan, A. D. Nelson, S.‐Y. Park, A. Acosta & A. R. Zinsmeister. (2016) Opioid analgesic use among patients presenting with acute abdominal pain and factors associated with surgical diagnoses. Neurogastroenterology & Motility 29:5.
Crossref
Crossref
Merja Kokki, Moona Kuronen, Toivo Naaranlahti, Timo Nyyssönen, Ira Pikkarainen, Sakari Savolainen & Hannu Kokki. (2016) Opioid-Induced Bowel Dysfunction in Patients Undergoing Spine Surgery: Comparison of Oxycodone and Oxycodone-Naloxone Treatment. Advances in Therapy 34:1, pages 236-251.
Crossref
Crossref
Stefan Müller-Lissner, Gabrio Bassotti, Benoit Coffin, Asbjørn Mohr Drewes, Harald Breivik, Elon Eisenberg, Anton Emmanuel, Françoise Laroche, Winfried Meissner & Bart Morlion. (2016) Opioid-Induced Constipation and Bowel Dysfunction: A Clinical Guideline. Pain Medicine, pages pnw255.
Crossref
Crossref
Frida Hjalte, Gunnel Ragnarson Tennvall, Karl-Olof Welin & Dagmar Westerling. (2016) Treatment of Severe Pain and Opioid-induced Constipation: An Observational Study of Quality of Life, Resource Use, and Costs in Sweden. Pain and Therapy 5:2, pages 227-236.
Crossref
Crossref
Anton Emmanuel, Martin Johnson, Paula McSkimming & Sara Dickerson. (2016) Laxatives Do Not Improve Symptoms of Opioid-Induced Constipation: Results of a Patient Survey. Pain Medicine, pages pnw240.
Crossref
Crossref
Sita Chokhavatia, Elizabeth S. John, Mary Barna Bridgeman & Deepali Dixit. (2016) Constipation in Elderly Patients with Noncancer Pain: Focus on Opioid-Induced Constipation. Drugs & Aging 33:8, pages 557-574.
Crossref
Crossref
Matias Nilsson, Jakob L. Poulsen, Christina Brock, Thomas H. Sandberg, Mikkel Gram, Jens B. Frøkjær, Klaus Krogh & Asbjørn M. Drewes. (2016) Opioid-induced bowel dysfunction in healthy volunteers assessed with questionnaires and MRI. European Journal of Gastroenterology & Hepatology 28:5, pages 514-524.
Crossref
Crossref
Jakob L Poulsen, Matias Nilsson, Christina Brock, Thomas H Sandberg, Klaus Krogh & Asbjørn M Drewes. (2016) The Impact of Opioid Treatment on Regional Gastrointestinal Transit. Journal of Neurogastroenterology and Motility 22:2, pages 282-291.
Crossref
Crossref
Asbjørn M. Drewes, Pia Munkholm, Magnus Simrén, Harald Breivik, Ulf E. Kongsgaard, Jan G. Hatlebakk, Lars Agreus, Maria Friedrichsen & Lona L. Christrup. (2016) Definition, diagnosis and treatment strategies for opioid-induced bowel dysfunction–Recommendations of the Nordic Working Group. Scandinavian Journal of Pain 11:1, pages 111-122.
Crossref
Crossref
Alfred D. Nelson & Michael Camilleri. (2016) Opioid-induced constipation: advances and clinical guidance. Therapeutic Advances in Chronic Disease 7:2, pages 121-134.
Crossref
Crossref
Renee M. Holder & Diane Rhee. (2016) Novel Oral Therapies for Opioid-induced Bowel Dysfunction in Patients with Chronic Noncancer Pain. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 36:3, pages 287-299.
Crossref
Crossref
Charles E. Argoff, Michael J. Brennan, Michael Camilleri, Andrew Davies, Jeffrey Fudin, Katherine E. Galluzzi, Jeffrey Gudin, Anthony Lembo, Steven P. Stanos & Lynn R. Webster. (2015) Consensus Recommendations on Initiating Prescription Therapies for Opioid-Induced Constipation. Pain Medicine 16:12, pages 2324-2337.
Crossref
Crossref
M. Nilsson, T. H. Sandberg, J. L. Poulsen, M. Gram, J. B. Frøkjaer, L. R. Østergaard, K. Krogh, C. Brock & A. M. Drewes. (2015) Quantification and variability in colonic volume with a novel magnetic resonance imaging method. Neurogastroenterology & Motility 27:12, pages 1755-1763.
Crossref
Crossref
Jakob Lykke Poulsen, Christina Brock, Anne Estrup Olesen, Matias Nilsson & Asbjørn Mohr Drewes. (2015) Evolving paradigms in the treatment of opioid-induced bowel dysfunction. Therapeutic Advances in Gastroenterology 8:6, pages 360-372.
Crossref
Crossref
Lynn R. Webster. (2015) Opioid-Induced Constipation. Pain Medicine 16:suppl 1, pages S16-S21.
Crossref
Crossref
MA Ueberall. (2015) Differential Gastrointestinal Effects of Who-Step III Opioids in Low Back Pain Patients with vs. Without Constipation: Post-Hoc Analysis of Data from a 12-Week Prospective, Open-Label Blinded Endpoint Streamlined Study. Global Journal of Anesthesiology, pages 037-051.
Crossref
Crossref
Graziella Madeo, Tommaso Schirinzi, Silvia Natoli, Mariangela Pierantozzi, Alessandro Stefani, Mario Dauri & Antonio Pisani. (2015) Efficacy and safety profile of prolonged release oxycodone in combination with naloxone (OXN PR) in Parkinson’s disease patients with chronic pain. Journal of Neurology 262:9, pages 2164-2170.
Crossref
Crossref
Alfred D. Nelson & Michael Camilleri. (2015) Chronic opioid induced constipation in patients with nonmalignant pain: challenges and opportunities. Therapeutic Advances in Gastroenterology 8:4, pages 206-220.
Crossref
Crossref
Jan Poelaert, Gineke Koopmans-Klein, Alioune Dioh, Frédéric Louis, Mayken Gorissen, David Logé, Joeri Van Op den bosch & Yvonne J.B. van Megen. (2015) Treatment With Prolonged-Release Oxycodone/Naloxone Improves Pain Relief and Opioid-Induced Constipation Compared With Prolonged-Release Oxycodone in Patients With Chronic Severe Pain and Laxative-Refractory Constipation. Clinical Therapeutics 37:4, pages 784-792.
Crossref
Crossref
Ryan Abbott, Ian Ayres, Ed Hui & Ka-Kit Hui. (2014) Effect of Perineal Self-Acupressure on Constipation: A Randomized Controlled Trial. Journal of General Internal Medicine 30:4, pages 434-439.
Crossref
Crossref
Sam H. Ahmedzai, Wojciech Leppert, Marcin Janecki, Artur Pakosz, Mark Lomax, Heike Duerr & Michael Hopp. (2014) Long-term safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate-to-severe chronic cancer pain. Supportive Care in Cancer 23:3, pages 823-830.
Crossref
Crossref
Bart Morlion, Katri Elina Clemens & Will Dunlop. (2014) Quality of Life and Healthcare Resource in Patients Receiving Opioids for Chronic Pain: A Review of the Place of Oxycodone/Naloxone. Clinical Drug Investigation 35:1, pages 1-11.
Crossref
Crossref
Elisabeth CW Neefjes, Maurice JDL van der Vorst, Manon SA Boddaert, Wouter WA Zuurmond, Hans J van der Vliet, Aart Beeker, Hendrik P van den Berg, Cornelis J van Groeningen, Suzan Vrijaldenhoven & Henk MW Verheul. (2014) Clinical evaluation of the efficacy of methylnaltrexone in resolving constipation induced by different opioid subtypes combined with laboratory analysis of immunomodulatory and antiangiogenic effects of methylnaltrexone. BMC Palliative Care 13:1.
Crossref
Crossref
Arturo Cuomo, Gennaro Russo, Gennaro Esposito, Cira Antonietta Forte, Marianna Connola & Claudio Marcassa. (2013) Efficacy and Gastrointestinal Tolerability of Oral Oxycodone/Naloxone Combination for Chronic Pain in Outpatients With Cancer. American Journal of Hospice and Palliative Medicine® 31:8, pages 867-876.
Crossref
Crossref
M. Blagden, J. Hafer, H. Duerr, M. Hopp & B. Bosse. (2014) Long‐term evaluation of combined prolonged‐release oxycodone and naloxone in patients with moderate‐to‐severe chronic pain: pooled analysis of extension phases of two Phase III trials. Neurogastroenterology & Motility 26:12, pages 1792-1801.
Crossref
Crossref
V. C. P. C. Dongen, P. J. L. Vanelderen, G. Koopmans‐Klein, Y. J. B. Megen, J. Van Zundert & F. J. P. M. Huygen. (2014)
Patient preference with respect to QoL and reduction in opioid‐induced constipation (
OIC
) after treatment with prolonged‐release (
PR
) oxycodone/naloxone compared with previous analgesic therapy [
PREFER
study]
. International Journal of Clinical Practice 68:11, pages 1364-1375.
Crossref
Crossref
M. Camilleri, D. A. Drossman, G. Becker, L. R. Webster, A. N. Davies & G. M. Mawe. (2014) Emerging treatments in neurogastroenterology: a multidisciplinary working group consensus statement on opioid-induced constipation. Neurogastroenterology & Motility 26:10, pages 1386-1395.
Crossref
Crossref
Spencer Dorn, Anthony Lembo & Filippo Cremonini. (2014) Opioid-Induced Bowel Dysfunction: Epidemiology, Pathophysiology, Diagnosis and Initial Therapeutic Approach. The American Journal of Gastroenterology Supplements 2:1, pages 31-37.
Crossref
Crossref
Anne Laure Tarrerias, Laurent Abramowitz, Marc M.L. Marty, Pierre Coulom, Ghislain Staumont, Christophe Merlette, Véronique Berger, Bernard Savarieau & Philippe Ducrotté. (2014) Efficacy of a CO2-releasing suppository in dyschezia: A double-blind, randomized, placebo-controlled clinical trial. Digestive and Liver Disease 46:8, pages 682-687.
Crossref
Crossref
Anne Z. DePriest & Katie Miller. (2014) Oxycodone/Naloxone: Role in Chronic Pain Management, Opioid-Induced Constipation, and Abuse Deterrence. Pain and Therapy 3:1, pages 1-15.
Crossref
Crossref
Sabine Hesselbarth, Oliver Löwenstein & Thomas Cegla. (2014) Effects of prolonged-release oxycodone/naloxone on pain control, bowel function and quality of life: A prospective observational study. Scandinavian Journal of Pain 5:2, pages 75-81.
Crossref
Crossref
Celeste B. Burness & Gillian M. Keating. (2014) Oxycodone/Naloxone Prolonged-Release: A Review of Its Use in the Management of Chronic Pain While Counteracting Opioid-Induced Constipation. Drugs 74:3, pages 353-375.
Crossref
Crossref
Lalit Kumar, Chris Barker & Anton Emmanuel. (2014) Opioid-Induced Constipation: Pathophysiology, Clinical Consequences, and Management. Gastroenterology Research and Practice 2014, pages 1-6.
Crossref
Crossref
William C. Becker, Liana Fraenkel, Jennifer E. Edelman, Stephen R. Holt, Janis Glover, Robert D. Kerns & David A. Fiellin. (2013) Instruments to assess patient-reported safety, efficacy, or misuse of current opioid therapy for chronic pain: A systematic review. Pain 154:6, pages 905-916.
Crossref
Crossref
Stacie K. Levine & Joseph W. Shega. 2013. Evidence-Based Practice in Palliative Medicine. Evidence-Based Practice in Palliative Medicine
129
134
.
Antonio Gatti, Manuela Casali, Marzia Lazzari, Giuseppe Tufaro, Paolo Gafforio, Claudia Silvestri, Claudio Marcassa & Alessandro F. Sabato. (2012) Prolonged-Release Oxycodone/Naloxone in Nonmalignant Pain: Single-Center Study in Patients with Constipation. Advances in Therapy 30:1, pages 41-59.
Crossref
Crossref
Christina Brock, Søren Schou Olesen, Anne Estrup Olesen, Jens Brøndum Frøkjaer, Trine Andresen & Asbjørn Mohr Drewes. (2012) Opioid-Induced Bowel Dysfunction. Drugs 72:14, pages 1847-1865.
Crossref
Crossref
K Kuusniemi, J Zöllner, S Sjövall, J Huhtala, P Karjalainen, M Kokki, J Lemken, J Oppermann & H Kokki. (2012) Prolonged-release Oxycodone/Naloxone in Postoperative Pain Management: From a Randomized Clinical Trial to Usual Clinical Practice. Journal of International Medical Research 40:5, pages 1775-1793.
Crossref
Crossref
Gálvez Rafael, Provencio Mariano, Sanz-Ortiz Jaime, Ribera Ma Victoria, Esteban Emilio, Collado Francisco, Vara Francisco, Díaz Pilar, Rocafort Javier, Cobo Manuel, Traseira Susana & Brosa Max. (2013) Análisis económico de oxicodona LP/ naloxona LP en el manejo del dolor intenso y el estreñimiento asociado al tratamiento con opioides en España. PharmacoEconomics Spanish Research Articles 9:1, pages 23-34.
Crossref
Crossref
Sam H Ahmedzai, Friedemann Nauck, Gil Bar-Sela, Björn Bosse, Petra Leyendecker & Michael Hopp. (2011) A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer pain. Palliative Medicine 26:1, pages 50-60.
Crossref
Crossref
Nagi B. KumarNagi B. Kumar. 2012. Nutritional Management of Cancer Treatment Effects. Nutritional Management of Cancer Treatment Effects
221
244
.
Marie-Louise Navez, Florentin Clère, Youlia Kirova, Claire Josse, Bertrand Chuberre & Christian Caussé. (2011) Caractéristiques cliniques des douleurs cancéreuses sévères chez les patients traités par oxycodone. Cohorte OCS2. Douleurs : Evaluation - Diagnostic - Traitement 12:3, pages 110-122.
Crossref
Crossref
Michael Camilleri. (2011) Opioid-Induced Constipation: Challenges and Therapeutic Opportunities. American Journal of Gastroenterology 106:5, pages 835-842.
Crossref
Crossref
K. E. Clemens, I. Quednau & E. Klaschik. (2011) Bowel function during pain therapy with oxycodone/naloxone prolonged-release tablets in patients with advanced cancer. International Journal of Clinical Practice 65:4, pages 472-478.
Crossref
Crossref
Anne Estrup Olesen & Asbjørn Mohr Drewes. (2011) Validated tools for evaluating opioid-induced bowel dysfunction. Advances in Therapy 28:4, pages 279-294.
Crossref
Crossref
Michael Camilleri, Margaret Rothman, Kai Fai Ho & Mila Etropolski. (2011) Validation of a Bowel Function Diary for Assessing Opioid-Induced Constipation. American Journal of Gastroenterology 106:3, pages 497-506.
Crossref
Crossref
MA Ueberall, S Müller-Lissner, C Buschmann-Kramm & B Bosse. (2011) The Bowel Function Index for Evaluating Constipation in Pain Patients: Definition of a Reference Range for a Non-Constipated Population of Pain Patients. Journal of International Medical Research 39:1, pages 41-50.
Crossref
Crossref
Oliver Löwenstein, Petra Leyendecker, Eberhard A Lux, Mark Blagden, Karen H Simpson, Michael Hopp, Björn Bosse & Karen Reimer. (2010) Efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of moderate/severe chronic non-malignant pain: results of a prospectively designed pooled analysis of two randomised, double-blind clinical trials. BMC Clinical Pharmacology 10:1.
Crossref
Crossref
B. M. R. Spiegel, R. Bolus, N. Agarwal, G. Sayuk, L. A. Harris, S. Lucak, E. Esrailian, W. D. Chey, A. Lembo, H. Karsan, K. Tillisch, J. Talley & L. Chang. (2010) Measuring symptoms in the irritable bowel syndrome: development of a framework for clinical trials. Alimentary Pharmacology & Therapeutics 32:10, pages 1275-1291.
Crossref
Crossref
. (2010) Current World Literature. Current Opinion in Anaesthesiology 23:5, pages 671-678.
Crossref
Crossref
Peter Holzer. (2010) Opioid antagonists for prevention and treatment of opioid-induced gastrointestinal effects. Current Opinion in Anaesthesiology 23:5, pages 616-622.
Crossref
Crossref
Stefan Mueller-Lissner. (2010) Fixed combination of oxycodone with naloxone: a new way to prevent and treat opioid-induced constipation. Advances in Therapy 27:9, pages 581-590.
Crossref
Crossref
N. Béziaud, J.-M. Pellat, V. Granger & M. Baudrant-Boga. (2010) Antagonistes opioïdes et constipationOpioids antagonists and constipation. Douleur et Analgésie 23:3, pages 182-188.
Crossref
Crossref
A. Sandner-Kiesling, P. Leyendecker, M. Hopp, L. Tarau, J. Lejcko, W. Meissner, P. Sevcik, M. Hakl, R. Hrib, R. Uhl, H. Dürr & K. Reimer. (2010) Long-term efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of non-cancer chronic pain. International Journal of Clinical Practice 64:6, pages 763-774.
Crossref
Crossref